Literature DB >> 18537207

Endohexosaminidase-catalysed glycosylation with oxazoline donors: fine tuning of catalytic efficiency and reversibility.

Thomas W D F Rising1, Christoph D Heidecke, James W B Moir, Zhenlian Ling, Antony J Fairbanks.   

Abstract

A complete series of oxazoline di-, tri-, tetra-, and hexasaccharides, corresponding to the core sections of N-linked glycoprotein high mannose glycans, together with the corresponding oligosaccharides containing a central glucose unit, were synthesised and tested as glycosyl donors for glycosylation of a GlcNAcAsn glycosyl amino acid catalysed by the endohexosaminidases M (Endo M), A (Endo A) and H (Endo H). Whilst Endo H did not catalyse any glycosylation reactions, both Endo M and Endo A efficiently catalysed glycosylations that were not limited to donors containing the Manbeta(1-->4)GlcNAc linkage. Precise structure activity relationships and time course studies have revealed fine-tuning of the efficiency of the synthetic processes which correlated both with the enzyme used and the precise oxazoline structure. Efficient irreversible glycosylation was achievable with both Endo M and Endo A, further demonstrating the use of structurally modified oxazoline donors as transition state mimics in order to promote enzyme-catalysed synthesis, whilst precluding product hydrolysis; enzymes in these cases display "glycoligase" activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537207     DOI: 10.1002/chem.200800365

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  20 in total

Review 1.  Emerging technologies for making glycan-defined glycoproteins.

Authors:  Lai-Xi Wang; Joseph V Lomino
Journal:  ACS Chem Biol       Date:  2011-12-14       Impact factor: 5.100

2.  Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor.

Authors:  Guozhang Zou; Hirofumi Ochiai; Wei Huang; Qiang Yang; Cishan Li; Lai-Xi Wang
Journal:  J Am Chem Soc       Date:  2011-11-01       Impact factor: 15.419

3.  Convergent synthesis of homogeneous Glc1Man9GlcNAc2-protein and derivatives as ligands of molecular chaperones in protein quality control.

Authors:  Mohammed N Amin; Wei Huang; Rahman M Mizanur; Lai-Xi Wang
Journal:  J Am Chem Soc       Date:  2011-08-19       Impact factor: 15.419

4.  Unusual transglycosylation activity of Flavobacterium meningosepticum endoglycosidases enables convergent chemoenzymatic synthesis of core fucosylated complex N-glycopeptides.

Authors:  Wei Huang; Jie Li; Lai-Xi Wang
Journal:  Chembiochem       Date:  2011-03-04       Impact factor: 3.164

Review 5.  Endoglycosidases for the Synthesis of Polysaccharides and Glycoconjugates.

Authors:  Chao Li; Lai-Xi Wang
Journal:  Adv Carbohydr Chem Biochem       Date:  2016-08-23       Impact factor: 12.200

6.  Arthrobacter endo-beta-N-acetylglucosaminidase shows transglycosylation activity on complex-type N-glycan oxazolines: one-pot conversion of ribonuclease B to sialylated ribonuclease C.

Authors:  Wei Huang; Qiang Yang; Midori Umekawa; Kenji Yamamoto; Lai-Xi Wang
Journal:  Chembiochem       Date:  2010-07-05       Impact factor: 3.164

Review 7.  Chemoenzymatic Methods for the Synthesis of Glycoproteins.

Authors:  Chao Li; Lai-Xi Wang
Journal:  Chem Rev       Date:  2018-08-24       Impact factor: 60.622

8.  Chemoenzymatic synthesis of N-linked neoglycoproteins through a chitinase-catalyzed transglycosylation.

Authors:  Cishan Li; Wei Huang; Lai-Xi Wang
Journal:  Bioorg Med Chem       Date:  2008-08-26       Impact factor: 3.641

Review 9.  Enzymatic transglycosylation for glycoconjugate synthesis.

Authors:  Lai-Xi Wang; Wei Huang
Journal:  Curr Opin Chem Biol       Date:  2009-09-18       Impact factor: 8.822

10.  A two-step enzymatic glycosylation of polypeptides with complex N-glycans.

Authors:  Joseph V Lomino; Andreas Naegeli; Jared Orwenyo; Mohammed N Amin; Markus Aebi; Lai-Xi Wang
Journal:  Bioorg Med Chem       Date:  2013-02-18       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.